![](/us.svg)
Trademark: 88077682
Status Date
Monday, August 15, 2022
Filing Date
Tuesday, August 14, 2018
Published for Opposition
Tuesday, November 6, 2018
Abandoned Date
Monday, August 15, 2022
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment of genetic diseases and disorders and pharmaceutical preparations for use in enzyme therapy
Aug 15, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 15, 2022
Abandonment - No Use Statement Filed
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2022
Sou Extension 5 Granted
Jan 6, 2022
Sou Extension 5 Filed
Jan 14, 2022
Case Assigned To Intent To Use Paralegal
Jan 6, 2022
Sou Teas Extension Received
Jul 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 5, 2021
Sou Extension 4 Granted
Jul 5, 2021
Sou Extension 4 Filed
Jul 5, 2021
Sou Teas Extension Received
Jan 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2021
Sou Extension 3 Granted
Jan 5, 2021
Sou Extension 3 Filed
Jan 5, 2021
Sou Teas Extension Received
Jul 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 3, 2020
Sou Extension 2 Granted
Jul 3, 2020
Sou Extension 2 Filed
Jul 3, 2020
Sou Teas Extension Received
Jan 9, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2020
Sou Extension 1 Granted
Jan 7, 2020
Sou Extension 1 Filed
Jan 7, 2020
Sou Teas Extension Received
Jul 9, 2019
Noa E-Mailed - Sou Required From Applicant
May 30, 2019
Changes/Corrections After Pub Approval Entered
May 28, 2019
Assigned To Petition Staff
May 16, 2019
Extension Of Time To Oppose Process - Terminated
May 2, 2019
Teas Post Publication Amendment Received
Dec 5, 2018
Extension Of Time To Oppose Received
Nov 6, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 6, 2018
Published For Opposition
Oct 17, 2018
Notification Of Notice Of Publication E-Mailed
Sep 26, 2018
Approved For Pub - Principal Register
Sep 24, 2018
Assigned To Examiner
Aug 22, 2018
New Application Office Supplied Data Entered
Aug 17, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24